First Turn Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.6M Sell
248,475
-15,818
-6% -$2.43M 4.54% 7
2025
Q4
$46M Sell
264,293
-55,480
-17% -$10.1M 5.26% 3
2025
Q3
$46.1M Sell
319,773
-52,899
-14% -$6.48M 6.91% 1
2025
Q2
$37.5M Sell
372,672
-28,957
-7% -$2.21M 7% 1
2025
Q1
$30.6M Sell
401,629
-45,351
-10% -$3.47M 6.18% 1
2024
Q4
$30.9M Buy
446,980
+90,529
+25% +$6.52M 5.53% 1
2024
Q3
$26M Buy
356,451
+33,091
+10% +$2.44M 4.12% 3
2024
Q2
$21.7M Buy
+323,360
New +$12.5M 3.52% 8

Other funds holding INSM

First Turn Management's INSM Position: Q1 2026 in Review

First Turn Management reduced its Insmed (INSM) stake by 6% in Q1 2026, selling an estimated $2.43M and leaving 248,475 shares worth $40.6M. The position accounts for 4.54% of the portfolio, ranked #7.

First Turn Management first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $46.1M in Q3 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • First Turn Management held 248,475 shares of Insmed worth $40.6M as of Q1 2026.
  • First Turn Management sold 15,818 Insmed shares in Q1 2026, an estimated $2.43M.
  • Insmed made up 4.54% of First Turn Management's portfolio in Q1 2026, its #7 holding.
  • First Turn Management first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • First Turn Management's Insmed position peaked at $46.1M in Q3 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on First Turn Management's 13F filing for Q1 2026, filed 15 May 2026.